We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$14.6B
AUM Growth
+$423M
Cap. Flow
-$220M
Cap. Flow %
-1.51%
Top 10 Hldgs %
9.47%
Holding
503
New
43
Increased
174
Reduced
117
Closed
38

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$61.3M
2
XEL icon
Xcel Energy
XEL
+$51.9M
3
WEC icon
WEC Energy
WEC
+$43.5M
4
AMD icon
Advanced Micro Devices
AMD
+$42.7M
5
CNC icon
Centene
CNC
+$42.6M

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 18.13%
3 Industrials 16.11%
4 Consumer Discretionary 13.66%
5 Financials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLK icon
251
Westlake Corp
WLK
$9.26B
$20.4M 0.14%
293,175
+159,925
+120% +$10.6M
TTE icon
252
TotalEnergies
TTE
$193B
$20.2M 0.14%
362,424
+16,254
+5% +$887K
AIMT
253
DELISTED
Aimmune Therapeutics
AIMT
$20.1M 0.14%
964,906
TSN icon
254
Tyson Foods
TSN
$21.5B
$20M 0.14%
247,432
+126,982
+105% +$9.78M
WFC icon
255
Wells Fargo
WFC
$254B
$19.8M 0.14%
418,391
+18,764
+5% +$878K
SRE icon
256
Sempra
SRE
$58.1B
$19.4M 0.13%
282,034
+12,648
+5% +$830K
PHM icon
257
Pultegroup
PHM
$25.2B
$19.3M 0.13%
611,300
+135,200
+28% +$4.22M
ACAD icon
258
Acadia Pharmaceuticals
ACAD
$4.51B
$19.1M 0.13%
+715,382
New +$18.3M
PLD icon
259
Prologis
PLD
$136B
$19.1M 0.13%
238,556
+10,698
+5% +$814K
SYY icon
260
Sysco
SYY
$40.8B
$19.1M 0.13%
269,493
+12,085
+5% +$860K
CF icon
261
CF Industries
CF
$19.6B
$18.8M 0.13%
402,683
+312,088
+344% +$13.5M
THO icon
262
Thor Industries
THO
$4.06B
$18.8M 0.13%
321,711
-149,200
-32% -$9.05M
CCL icon
263
Carnival Corporation Ltd
CCL
$38.1B
$18.6M 0.13%
398,685
+17,880
+5% +$936K
TREE icon
264
LendingTree
TREE
$551M
$17.9M 0.12%
42,563
-6,825
-14% -$2.61M
NEM icon
265
Newmont
NEM
$96.2B
$17.8M 0.12%
462,600
+60,550
+15% +$2.05M
EVRG icon
266
Evergy
EVRG
$19.4B
$17.6M 0.12%
292,443
+13,115
+5% +$767K
MA icon
267
Mastercard
MA
$498B
$17.4M 0.12%
65,730
-1,400
-2% -$350K
HR
268
DELISTED
Healthcare Realty Trust Incorporated
HR
$17.3M 0.12%
553,200
-97,950
-15% -$3.1M
MO icon
269
Altria Group
MO
$125B
$17.3M 0.12%
364,370
+16,340
+5% +$856K
NVS icon
270
Novartis
NVS
$302B
$17.1M 0.12%
186,807
-117,547
-39% -$9.95M
RARX
271
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$17M 0.12%
+566,120
New +$13M
WTM icon
272
White Mountains Insurance
WTM
$5.33B
$17M 0.12%
16,650
ODT
273
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$16.9M 0.12%
+459,968
New +$11M
ABT icon
274
Abbott
ABT
$188B
$16.8M 0.12%
199,177
-76,346
-28% -$6.01M
LEA icon
275
Lear
LEA
$7.39B
$16.6M 0.11%
119,450
+99,150
+488% +$13.9M

Similar funds

Carillon Tower Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Carillon Tower Advisers held 503 positions worth $14.6B, up 3% from $14.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Carillon Tower Advisers's Q2 2019 filing shows 43 new, 174 increased, 117 reduced and 38 closed positions. Its largest new stake was Marsh: 640,125 shares worth $63.9M. The largest sale was Tableau Software, Inc., an estimated $120M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Carillon Tower Advisers's largest Q2 2019 buy was Marsh: 640,125 shares worth $63.9M.
  • Carillon Tower Advisers added most to Xcel Energy in Q2 2019, an estimated $51.9M increase.
  • Carillon Tower Advisers's biggest Q2 2019 reduction was ServiceNow, cutting an estimated $55.7M.
  • Carillon Tower Advisers fully exited Tableau Software, Inc. in Q2 2019, selling an estimated $120M.
  • Carillon Tower Advisers's ten largest holdings make up 9.5% of its $14.6B portfolio in Q2 2019.
  • Carillon Tower Advisers opened 43 new positions and closed 38 in Q2 2019.
  • Carillon Tower Advisers's portfolio value rose 3% quarter-over-quarter to $14.6B.

Based on Carillon Tower Advisers's 13F filing for Q2 2019, filed 8 Aug 2019.